IPO Boutique

Co-Diagnostics, Inc. IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on Co-Diagnostics, Inc., and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Co-Diagnostics, Inc.CODX -
NASDAQ
$6.35-$6.75 $6.00 $6.001.2 million7/12/2017
WallachBeth Capital, LLC, Network 1 Financial Securities
Co-Manager(s):
Health Care
Filing(s):

Filed 2017-04-28
Terms Added 2017-06-09
Updated Prospectus 2017-07-06



Co-Diagnostics, Inc. Quote & Chart - Click for current quote - CODX

About Co-Diagnostics, Inc. (adapted from Co-Diagnostics, Inc. prospectus):
Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that has developed and intends to manufacture and sell reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules (DNA or RNA), and to sell diagnostic equipment from other manufacturers as self-contained lab systems.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "CODX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved